International Biotechnology Trust plc
Share this pagePrint this page

Portfolio Analysis

30 April 2016

Summary

 

IBT Portfolio NAV (m)

188

Number of Portfolio Companies

86

Quoted Investments

60

Unquoted Investments

26

 

NAV % Quoted / Unquoted Split
NAV % by Geography

Quoted

89%

United States / Canada

81%

Unquoted

11%

Europe

19%

Total

100% 

Total

100%

 

 

 

 

 

NAV % by Subsector
NAV % by Market Capitalisation

 

 

Therapeutics

88%

Large-Cap (>$10bn)

44%

Medical Devices

2%

Mid-Cap (>$1bn, <$10bn)

25%

Specialty Pharma

8%

Small-Cap (<$1bn)

20%

Life Sciences, Tools

2%

Unquoted

11%

 

NAV % by Portfolio Profitability
NAV % by Revenue Split

 

 

Profitable

58%

Revenue Generating

71%

Turning Profitable

5%

Near Revenue

4%

Unprofitable

37%

No Sales in the near term

25%

Total100%

Total

100%